NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000973

Registered date:07/01/2008

An early phase II study of delayed local treatment with surgery and radiation, that follows high dose chemotherapy with peripheral blood stem cell transplantation in patients with advanced neuroblastoma

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedNeuroblastoma
Date of first enrollment2005/12/01
Target sample size16
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Chemothrapy, surgery and radiation in INSS satge 4 neuroblastoma

Outcome(s)

Primary Outcome1-year progression-free survival rate from the 12th week of the protocol
Secondary Outcome2-year progression-free and overall survival rates, clinical response rate at the 12th week of the protocol and that before surgery, the incidence of adverse events

Key inclusion & exclusion criteria

Age minimum1years-old
Age maximum18years-old
GenderMale and Female
Include criteria
Exclude criteriaActive double cancer; pregnant or possiblly pregnant women and those during breast feeding; patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment; patients with disease that may interfere with the protocol treatment

Related Information

Contact

public contact
Name Hiroyuki Shichino
Address 30-1,Oyaguchi-kamichou,Itabashiku,Tokyou,Japan Japan
Telephone 0339728111(2442)
E-mail shichino.hiroyuki@nihon-u.ac.jp
Affiliation Nihon University School Of Medicine Division of Pediatrics and Child Health
scientific contact
Name Hideo Mugishima
Address 30-1,Oyaguchi-kamichou,Itabashiku,Tokyou,Japan Japan
Telephone 03-3972-8111(2442)
E-mail
Affiliation Nihon University School Of Medicine Division of Pediatrics and Child Health